2024-01-012024-12-312024-12-31false07102415MAYORMEDICAL CONSULTING LIMITED2025-07-24falseiso4217:GBPxbrli:pure071024152023-12-31071024152024-12-31071024152024-01-012024-12-31071024152022-12-31071024152023-12-31071024152023-01-012023-12-3107102415bus:SmallEntities2024-01-012024-12-3107102415bus:AuditExempt-NoAccountantsReport2024-01-012024-12-3107102415bus:AbridgedAccounts2024-01-012024-12-3107102415bus:PrivateLimitedCompanyLtd2024-01-012024-12-3107102415core:WithinOneYear2024-12-3107102415core:AfterOneYear2024-12-3107102415core:WithinOneYear2023-12-3107102415core:AfterOneYear2023-12-3107102415core:ShareCapital2024-12-3107102415core:SharePremium2024-12-3107102415core:RevaluationReserve2024-12-3107102415core:OtherReservesSubtotal2024-12-3107102415core:RetainedEarningsAccumulatedLosses2024-12-3107102415core:ShareCapital2023-12-3107102415core:SharePremium2023-12-3107102415core:RevaluationReserve2023-12-3107102415core:OtherReservesSubtotal2023-12-3107102415core:RetainedEarningsAccumulatedLosses2023-12-3107102415core:LandBuildings2024-12-3107102415core:PlantMachinery2024-12-3107102415core:Vehicles2024-12-3107102415core:FurnitureFittings2024-12-3107102415core:OfficeEquipment2024-12-3107102415core:NetGoodwill2024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-12-3107102415core:ListedExchangeTraded2024-12-3107102415core:UnlistedNon-exchangeTraded2024-12-3107102415core:LandBuildings2023-12-3107102415core:PlantMachinery2023-12-3107102415core:Vehicles2023-12-3107102415core:FurnitureFittings2023-12-3107102415core:OfficeEquipment2023-12-3107102415core:NetGoodwill2023-12-3107102415core:IntangibleAssetsOtherThanGoodwill2023-12-3107102415core:ListedExchangeTraded2023-12-3107102415core:UnlistedNon-exchangeTraded2023-12-3107102415core:LandBuildings2024-01-012024-12-3107102415core:PlantMachinery2024-01-012024-12-3107102415core:Vehicles2024-01-012024-12-3107102415core:FurnitureFittings2024-01-012024-12-3107102415core:OfficeEquipment2024-01-012024-12-3107102415core:NetGoodwill2024-01-012024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107102415core:ListedExchangeTraded2024-01-012024-12-3107102415core:UnlistedNon-exchangeTraded2024-01-012024-12-3107102415core:MoreThanFiveYears2024-01-012024-12-3107102415core:Non-currentFinancialInstruments2024-12-3107102415core:Non-currentFinancialInstruments2023-12-3107102415dpl:CostSales2024-01-012024-12-3107102415dpl:DistributionCosts2024-01-012024-12-3107102415core:LandBuildings2024-01-012024-12-3107102415core:PlantMachinery2024-01-012024-12-3107102415core:Vehicles2024-01-012024-12-3107102415core:FurnitureFittings2024-01-012024-12-3107102415core:OfficeEquipment2024-01-012024-12-3107102415dpl:AdministrativeExpenses2024-01-012024-12-3107102415core:NetGoodwill2024-01-012024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3107102415dpl:GroupUndertakings2024-01-012024-12-3107102415dpl:ParticipatingInterests2024-01-012024-12-3107102415dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3107102415core:ListedExchangeTraded2024-01-012024-12-3107102415dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3107102415core:UnlistedNon-exchangeTraded2024-01-012024-12-3107102415dpl:CostSales2023-01-012023-12-3107102415dpl:DistributionCosts2023-01-012023-12-3107102415core:LandBuildings2023-01-012023-12-3107102415core:PlantMachinery2023-01-012023-12-3107102415core:Vehicles2023-01-012023-12-3107102415core:FurnitureFittings2023-01-012023-12-3107102415core:OfficeEquipment2023-01-012023-12-3107102415dpl:AdministrativeExpenses2023-01-012023-12-3107102415core:NetGoodwill2023-01-012023-12-3107102415core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3107102415dpl:GroupUndertakings2023-01-012023-12-3107102415dpl:ParticipatingInterests2023-01-012023-12-3107102415dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3107102415core:ListedExchangeTraded2023-01-012023-12-3107102415dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3107102415core:UnlistedNon-exchangeTraded2023-01-012023-12-3107102415core:NetGoodwill2024-12-3107102415core:IntangibleAssetsOtherThanGoodwill2024-12-3107102415core:LandBuildings2024-12-3107102415core:PlantMachinery2024-12-3107102415core:Vehicles2024-12-3107102415core:FurnitureFittings2024-12-3107102415core:OfficeEquipment2024-12-3107102415core:AfterOneYear2024-12-3107102415core:WithinOneYear2024-12-3107102415core:ListedExchangeTraded2024-12-3107102415core:UnlistedNon-exchangeTraded2024-12-3107102415core:ShareCapital2024-12-3107102415core:SharePremium2024-12-3107102415core:RevaluationReserve2024-12-3107102415core:OtherReservesSubtotal2024-12-3107102415core:RetainedEarningsAccumulatedLosses2024-12-3107102415core:NetGoodwill2023-12-3107102415core:IntangibleAssetsOtherThanGoodwill2023-12-3107102415core:LandBuildings2023-12-3107102415core:PlantMachinery2023-12-3107102415core:Vehicles2023-12-3107102415core:FurnitureFittings2023-12-3107102415core:OfficeEquipment2023-12-3107102415core:AfterOneYear2023-12-3107102415core:WithinOneYear2023-12-3107102415core:ListedExchangeTraded2023-12-3107102415core:UnlistedNon-exchangeTraded2023-12-3107102415core:ShareCapital2023-12-3107102415core:SharePremium2023-12-3107102415core:RevaluationReserve2023-12-3107102415core:OtherReservesSubtotal2023-12-3107102415core:RetainedEarningsAccumulatedLosses2023-12-3107102415core:NetGoodwill2022-12-3107102415core:IntangibleAssetsOtherThanGoodwill2022-12-3107102415core:LandBuildings2022-12-3107102415core:PlantMachinery2022-12-3107102415core:Vehicles2022-12-3107102415core:FurnitureFittings2022-12-3107102415core:OfficeEquipment2022-12-3107102415core:AfterOneYear2022-12-3107102415core:WithinOneYear2022-12-3107102415core:ListedExchangeTraded2022-12-3107102415core:UnlistedNon-exchangeTraded2022-12-3107102415core:ShareCapital2022-12-3107102415core:SharePremium2022-12-3107102415core:RevaluationReserve2022-12-3107102415core:OtherReservesSubtotal2022-12-3107102415core:RetainedEarningsAccumulatedLosses2022-12-3107102415core:AfterOneYear2024-01-012024-12-3107102415core:WithinOneYear2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:CostValuation2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-01-012024-12-3107102415core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3107102415core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3107102415core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3107102415core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3107102415core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3107102415bus:Director12024-01-012024-12-3107102415bus:Director22024-01-012024-12-31071024151bus:Director22023-12-31071024151bus:Director22024-01-012024-12-31071024151bus:Director22024-12-31071024152023-12-31071024152024-01-012024-12-31071024152024-12-31

MAYORMEDICAL CONSULTING LIMITED

Registered Number
07102415
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

MAYORMEDICAL CONSULTING LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Directors

MAYOR, Raka
MAYOR, Sunil Kumar, Dr

Registered Address

Ramsay Brown Llp 915
High Road
North Finchley
N12 8QJ

Registered Number

07102415 (England and Wales)
MAYORMEDICAL CONSULTING LIMITED
Balance Sheet as at
31 December 2024

Notes

2024

2023

£

£

£

£

Fixed assets
Intangible assets31,000,0001,000,000
Tangible assets425,99035,367
1,025,9901,035,367
Current assets
Debtors53,295,7991,813,233
Cash at bank and on hand5,2083,008,269
3,301,0074,821,502
Creditors amounts falling due within one year6(77,737)(1,672,568)
Net current assets (liabilities)3,223,2703,148,934
Total assets less current liabilities4,249,2604,184,301
Creditors amounts falling due after one year7-(41,860)
Net assets4,249,2604,142,441
Capital and reserves
Called up share capital22
Profit and loss account4,249,2584,142,439
Shareholders' funds4,249,2604,142,441
The financial statements were approved and authorised for issue by the Board of Directors on 24 July 2025, and are signed on its behalf by:
MAYOR, Raka
Director
Registered Company No. 07102415
MAYORMEDICAL CONSULTING LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Intangible assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
Goodwill
Goodwill, being the amount paid in connection with the acquisition of business in 2020, is being amortised evenly over its estimated useful life of nil years.
Tangible fixed assets and depreciation
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight line method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis. Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows:

Reducing balance (%)Straight line (years)
Plant and machinery25-
Fixtures and fittings-25
Vehicles25-
2.Average number of employees

20242023
Average number of employees during the year00
3.Intangible assets

Total

£
Cost or valuation
At 01 January 241,000,000
At 31 December 241,000,000
Net book value
At 31 December 241,000,000
At 31 December 231,000,000
4.Tangible fixed assets

Total

£
Cost or valuation
At 01 January 2485,817
At 31 December 2485,817
Depreciation and impairment
At 01 January 2450,450
Charge for year9,377
At 31 December 2459,827
Net book value
At 31 December 2425,990
At 31 December 2335,367
5.Debtors: amounts due within one year

2024

2023

££
Trade debtors / trade receivables425,3141,558,045
Other debtors2,870,485255,188
Total3,295,7991,813,233
6.Creditors: amounts due within one year

2024

2023

££
Trade creditors / trade payables-16,180
Taxation and social security36,793-
Other creditors37,7571,650,212
Accrued liabilities and deferred income3,1876,176
Total77,7371,672,568
7.Creditors: amounts due after one year

2024

2023

££
Bank borrowings and overdrafts-41,860
Total-41,860
8.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
MAYOR, Sunil Kumar, Dr024,02724,0270
024,02724,0270
As at the year end, the director owed the company £24,027 (2023: £21,767). This amount was repaid by the directors after the balance sheet date.